Aeglea BioTherapeutics
is launching as paragon second spin out focused on developing potentially best in class antibodies for | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
50 of 50
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
antibodies were developed by our partners at paragon | Aeglea BioTherapeutics
Investor Presentation
July 2023
antibodies were developed by our partners at paragon | Aeglea BioTherapeutics
Related slides by other companies
AbCellera
Results
February 2022
is the most potent antibody in development against the omicron variant | AbCellera
23andMe
Investor Day
January 2022
agenda | 23andMe
AbCellera
Investor Conference
September 2021
breaking bottlenecks in a antibody therapeutics market | AbCellera
Berkeley Lights
Investor Conference
January 2021
customer success in antibody therapeutics | Berkeley Lights
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io